Cargando…
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
BACKGROUND: Patients with cancer are particularly susceptible to SARS-CoV-2 infection. The systemic inflammatory response is a pathogenic mechanism shared by cancer progression and COVID-19. We investigated systemic inflammation as a driver of severity and mortality from COVID-19, evaluating the pro...
Ejemplares similares
-
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
por: Cortellini, Alessio, et al.
Publicado: (2022) -
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
por: Pinato, David J, et al.
Publicado: (2021) -
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
por: Garrigós, Laia, et al.
Publicado: (2021) -
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
por: Pinato, David J., et al.
Publicado: (2021) -
318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
por: Pinato, D.J., et al.
Publicado: (2020)